EGI
NVAX icon

EAM Global Investors’s Novavax NVAX Stock Holding History

EAM Global Investors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-17,774
Closed -$1.48M – 169
2020
Q2 		$1.48M Buy
+17,774
New +$680K 0.67% 74
2018
Q2 		– Sell
-24,315
Closed -$1.02M – 175
2018
Q1 		$1.02M Buy
+24,315
New +$977K 0.53% 100

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

EAM Global Investors's NVAX Position: Q3 2020 in Review

EAM Global Investors sold out of Novavax (NVAX) in Q3 2020, closing a stake of 17,774 shares — an estimated $1.48M sold.

EAM Global Investors first reported a position in NVAX in Q1 2018 and held it in 2 quarters. The position peaked at $1.48M in Q2 2020. 311 funds tracked by Wall St. Rank hold NVAX as of Q3 2020.

  • EAM Global Investors reported no remaining Novavax position as of Q3 2020 after selling out during the quarter.
  • EAM Global Investors sold 17,774 Novavax shares in Q3 2020, an estimated $1.48M.
  • EAM Global Investors first reported a position in Novavax in Q1 2018 and held it in 2 quarters.
  • EAM Global Investors's Novavax position peaked at $1.48M in Q2 2020.
  • 311 funds tracked by Wall St. Rank held Novavax as of Q3 2020.

Based on EAM Global Investors's 13F filing for Q3 2020, filed 13 Nov 2020.